199 related articles for article (PubMed ID: 32152434)
1. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.
Yin L; Keeler GD; Zhang Y; Hoffman BE; Ling C; Qing K; Srivastava A
Gene Ther; 2021 Aug; 28(7-8):422-434. PubMed ID: 32152434
[TBL] [Abstract][Full Text] [Related]
2. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
[TBL] [Abstract][Full Text] [Related]
3. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.
Ling C; Lu Y; Cheng B; McGoogan KE; Gee SW; Ma W; Li B; Aslanidi GV; Srivastava A
J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445055
[TBL] [Abstract][Full Text] [Related]
4. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.
Glushakova LG; Lisankie MJ; Eruslanov EB; Ojano-Dirain C; Zolotukhin I; Liu C; Srivastava A; Stacpoole PW
Mol Genet Metab; 2009 Nov; 98(3):289-99. PubMed ID: 19586787
[TBL] [Abstract][Full Text] [Related]
5. Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model.
Ling C; Wang Y; Zhang Y; Ejjigani A; Yin Z; Lu Y; Wang L; Wang M; Li J; Hu Z; Aslanidi GV; Zhong L; Gao G; Srivastava A; Ling C
Hum Gene Ther; 2014 Dec; 25(12):1023-34. PubMed ID: 25296041
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-regulated non-viral vectors with improved tumor specificity in an orthotopic rat model of hepatocellular carcinoma.
Ronald JA; Katzenberg R; Nielsen CH; Jae HJ; Hofmann LV; Gambhir SS
Gene Ther; 2013 Oct; 20(10):1006-13. PubMed ID: 23719066
[TBL] [Abstract][Full Text] [Related]
7. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
10. Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.
Della Peruta M; Badar A; Rosales C; Chokshi S; Kia A; Nathwani D; Galante E; Yan R; Arstad E; Davidoff AM; Williams R; Lythgoe MF; Nathwani AC
Hum Gene Ther; 2015 Feb; 26(2):94-103. PubMed ID: 25569358
[TBL] [Abstract][Full Text] [Related]
11. Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors.
Ling C; Yin Z; Li J; Zhang D; Aslanidi G; Srivastava A
Mol Ther Methods Clin Dev; 2016; 3():16029. PubMed ID: 27200382
[TBL] [Abstract][Full Text] [Related]
12. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.
Ling C; Lu Y; Kalsi JK; Jayandharan GR; Li B; Ma W; Cheng B; Gee SW; McGoogan KE; Govindasamy L; Zhong L; Agbandje-McKenna M; Srivastava A
Hum Gene Ther; 2010 Dec; 21(12):1741-7. PubMed ID: 20545554
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6.
Zhong D; Lyu X; Fu X; Xie P; Liu M; He F; Huang G
Technol Cancer Res Treat; 2020; 19():1533033820967473. PubMed ID: 33073697
[TBL] [Abstract][Full Text] [Related]
14. MiR-26a-5p Inhibits Cell Proliferation and Enhances Doxorubicin Sensitivity in HCC Cells via Targeting AURKA.
Yuan YL; Yu H; Mu SM; Dong YD; Li Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819851833. PubMed ID: 31570091
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.
Kota J; Chivukula RR; O'Donnell KA; Wentzel EA; Montgomery CL; Hwang HW; Chang TC; Vivekanandan P; Torbenson M; Clark KR; Mendell JR; Mendell JT
Cell; 2009 Jun; 137(6):1005-17. PubMed ID: 19524505
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
Komoll RM; Hu Q; Olarewaju O; von Döhlen L; Yuan Q; Xie Y; Tsay HC; Daon J; Qin R; Manns MP; Sharma AD; Goga A; Ott M; Balakrishnan A
J Hepatol; 2021 Jan; 74(1):122-134. PubMed ID: 32738449
[TBL] [Abstract][Full Text] [Related]
17. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
18. Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.
Brown HC; Doering CB; Herzog RW; Ling C; Markusic DM; Spencer HT; Srivastava A; Srivastava A
Hum Gene Ther; 2020 Oct; 31(19-20):1114-1123. PubMed ID: 32657150
[TBL] [Abstract][Full Text] [Related]
19. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW
Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984
[TBL] [Abstract][Full Text] [Related]
20. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
